Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.

Grove Collaborative vs PetMed Express

Grove Collaborative Holdings and PetMed Express Inc are compared on this page, with Grove Collaborative and PetMed Express used interchangeably for readability. This page compares business models, financial performance, and market context in a neutral, accessible manner. It explains how each company operates, generates revenue, and sits within its sector without endorsing any outcome. Educational content, not financial advice.

Grove Collaborative Holdings and PetMed Express Inc are compared on this page, with Grove Collaborative and PetMed Express used interchangeably for readability. This page compares business models, fin...

Investment Analysis

Grove Collaborative

GROV

Pros

Grove Collaborative offers a unique direct-to-consumer platform focused on sustainable household and personal care products, carving a niche market.
The company maintains a relatively strong gross margin of over 53%, indicating efficiency in product cost management.
Recent quarterly results showed signs of sequential revenue growth and positive operating cash flow, suggesting improving operational momentum.

Considerations

Grove Collaborative’s revenue has declined notably over recent years, with a 21.5% decrease in 2024 and continued softness into 2025.
The company recorded consistent net losses, with a trailing twelve months loss of approximately $22 million, reflecting ongoing profitability challenges.
It holds a moderately high debt-to-equity ratio near 70%, which could pose financial risk if cash flows do not stabilize.

PetMed Express

PETS

Pros

PetMed Express operates as a leading pet pharmacy in the U.S., benefiting from a specialized market position and steady demand for pet healthcare products.
The company has a low price-to-sales ratio of about 0.2, indicating that the stock may be undervalued relative to its sales.
As a niche player in the pet pharmaceutical industry, PetMed Express can leverage demographic trends, including increased pet ownership and healthcare spending.

Considerations

PetMed Express is currently unprofitable with negative EBITDA, indicating ongoing operational challenges.
The stock is trading above some fair value estimates, suggesting potential valuation risks if growth expectations are not met.
The company faces sector risks including regulatory scrutiny and competitive pressures from larger online retailers and pharmacies.

Related Market Insights

The Convenience Kings: Why Time-Saving Stocks Are Worth Your Attention

Discover the 'Sigh of Relief' portfolio: invest in time-saving stocks driving the convenience economy. Explore market leaders transforming daily life with Nemo's thematic investing.

Aimee Silverwood | Financial Analyst

July 25, 2025

The Guilt-Free Collection: Why Ethical Investing Is No Longer Optional

Invest in companies driving positive change. Explore Nemo's Guilt-Free Collection of ethical stocks & ETFs, focusing on sustainability & long-term growth. Start from $1.

Aimee Silverwood | Financial Analyst

July 25, 2025

The Clean Living Revolution: Why Natural Products Are Reshaping Consumer Markets

Explore the Clean Living Revolution. Invest in natural, organic, and non-toxic product companies like Honest Co., Sprouts, & Natural Grocers. Start investing from $1 with Nemo.

Aimee Silverwood | Financial Analyst

July 25, 2025

Related Market Insights

The Convenience Kings: Why Time-Saving Stocks Are Worth Your Attention

Discover the 'Sigh of Relief' portfolio: invest in time-saving stocks driving the convenience economy. Explore market leaders transforming daily life with Nemo's thematic investing.

Aimee Silverwood | Financial Analyst

July 25, 2025

The Guilt-Free Collection: Why Ethical Investing Is No Longer Optional

Invest in companies driving positive change. Explore Nemo's Guilt-Free Collection of ethical stocks & ETFs, focusing on sustainability & long-term growth. Start from $1.

Aimee Silverwood | Financial Analyst

July 25, 2025

The Clean Living Revolution: Why Natural Products Are Reshaping Consumer Markets

Explore the Clean Living Revolution. Invest in natural, organic, and non-toxic product companies like Honest Co., Sprouts, & Natural Grocers. Start investing from $1 with Nemo.

Aimee Silverwood | Financial Analyst

July 25, 2025

Which Baskets Do They Appear In?

Guilt-Free Collection

Guilt-Free Collection

Invest in companies that are making a real difference. This collection features businesses committed to sustainability and ethical practices, carefully selected by our analysts for their positive impact and growth potential in our increasingly eco-conscious world.

Published: June 18, 2025

Sigh of Relief Portfolio

Sigh of Relief Portfolio

These companies are dedicated to giving you back your most valuable asset: time. By serving our universal desire for an easier life, these convenience-focused firms are becoming more integrated into daily routines, positioning them for sustained future growth.

Published: June 17, 2025

Clean Living

Clean Living

Tap into the growing movement toward natural products and wellness. This carefully selected group of stocks represents companies dedicated to providing pure, organic, and non-toxic alternatives across food, personal care, and household goods.

Published: June 17, 2025

Which Baskets Do They Appear In?

Guilt-Free Collection

Guilt-Free Collection

Invest in companies that are making a real difference. This collection features businesses committed to sustainability and ethical practices, carefully selected by our analysts for their positive impact and growth potential in our increasingly eco-conscious world.

Published: June 18, 2025

Sigh of Relief Portfolio

Sigh of Relief Portfolio

These companies are dedicated to giving you back your most valuable asset: time. By serving our universal desire for an easier life, these convenience-focused firms are becoming more integrated into daily routines, positioning them for sustained future growth.

Published: June 17, 2025

Clean Living

Clean Living

Tap into the growing movement toward natural products and wellness. This carefully selected group of stocks represents companies dedicated to providing pure, organic, and non-toxic alternatives across food, personal care, and household goods.

Published: June 17, 2025

Buy GROV or PETS in Nemo

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Grove Collaborative vs Laird Superfood

Grove Collaborative vs Laird Superfood

Grove Collaborative vs Veru

Grove Collaborative vs Veru

Grove Collaborative vs TDH

Grove Collaborative vs TDH

Frequently asked questions

About The Companies

Grove Collaborative (GROV)

Grove Collaborative Holdings (GROV) is a direct‑to‑consumer retailer of natural household and personal‑care products. It sells branded and private‑label goods via subscription and single‑purchase e‑commerce channels, aiming to combine convenience with sustainability messaging. Investors should know Grove operates in a crowded market against larger retailers and digital natives; scale, customer retention and unit economics are central to its prospects. With a market capitalisation of roughly $63m, the company sits in the small‑cap, higher‑risk segment where volatility, cash‑burn and potential equity dilution are realistic possibilities. Financial results may show trade‑offs between growth and profitability as management invests in marketing and fulfilment. This summary is educational and not personalised advice — prospective investors should review the company’s latest filings, cash runway, customer metrics and competitive positioning before deciding whether this stock fits their risk tolerance.

PetMed Express (PETS)

PetMed Express, trading as PETS, is a small-cap online pet pharmacy that sells prescription and over-the-counter medications, nutritional supplements and pet care products primarily in the US. The business operates an e-commerce platform and direct-to-consumer fulfilment, leveraging brand recognition built around the 1-800-PetMeds name. Investors should note the company’s modest market capitalisation (about $55.7m), which can mean lower liquidity and higher share price volatility compared with larger peers. Revenue drivers include repeat prescriptions and private-label products, while margins depend on sourcing, shipping costs and competitive pricing. Key risks include regulatory oversight of veterinary medicines, competition from larger retail and online players, and concentration of sales channels. For those considering PETS, view it as speculative and research operational performance, cash flow and regulatory developments carefully. This information is general and educational only, not personalised investment advice; values can fall as well as rise, so assess suitability for your circumstances.